Myocardial Infarction
Cytokine therapy stimulates neovascularization in heart attack models
Published in Heart Disease Weekly, May 30th, 2004
According to recent research from Japan, "pretreatment with a combination of granulocyte colony-stimulating factor (G-CSF) and stem cell factor (SCF) has been reported to attenuate left ventricular (LV) remodeling after acute myocardial infarction (MI). We here examined whether the cytokine treatment started after MI has also beneficial effects. Anterior MI was created in the recipient mice whose bone marrow had been replaced with that of transgenic mice expressing enhanced green fluorescent protein (GFP).
"We categorized mice into five groups according to the following treatment:...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Heart Disease Weekly
Source: Heart Disease Weekly (2004-05-30)
More Articles from Heart Disease Weekly
- Arrhythmia
Several factors combine to cause triggered arrhythmias in heart failure - Heart Failure Therapy
Valsartan offers benefits for treatment of heart failure - Heart Valve Replacement
Tissue engineering may create semilunar heart valves - Myocardial Ischemia
Elevated cardiac troponins in renal disease patients may predict a poor outcome - Transplant Medicine
Skeletal growth and maturation can lag behind after pediatric heart transplant - Acute Coronary Syndrome
Women affected with ACS at older age than men, and have delayed treatment - More from this issue of Heart Disease Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
